Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review
Conclusion:
This systematic review supports the use of low-dose vaginal estrogens for treating vulvar and vaginal atrophy in menopausal women without a concomitant progestogen. This review does not support increased endometrial hyperplasia or cancer risk with low-dose, unopposed vaginal estrogens; however, longer-term, real-world data are needed.
Source: Menopause - Category: OBGYN Tags: Review Article Source Type: research
More News: Cancer | Cancer & Oncology | Denmark Health | Endometrial Cancer | Men | Menopause | OBGYN | Study | USA Health | Women